Correction:
SEL1L
SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
Oncotarget
.
2018 Aug 24;9(66):32731.
doi: 10.18632/oncotarget.26066.
Authors
Marta Mellai
#
1
,
Monica Cattaneo
#
2
,
Alessandra Maria Storaci
2
,
Laura Annovazzi
1
,
Paola Cassoni
3
,
Antonio Melcarne
4
,
Pasquale De Blasio
5
,
Davide Schiffer
1
,
Ida Biunno
2
6
Affiliations
1
Neuro-Bio-Oncology Center/Policlinico di Monza Foundation, Vercelli 13100, Italy.
2
Institute for Genetic and Biomedical Research, National Research Council, Milan 20138, Italy.
3
Department of Medical Sciences, University of Turin/Città della Salute e della Scienza, Turin 10126, Italy.
4
Department of Neurosurgery, CTO Hospital/Città della Salute e della Scienza, Turin 10126, Italy.
5
ISENET Stem Cell Bank, Milan 20138, Italy.
6
IRCCS-Multimedica, Milan 20138, Italy.
#
Contributed equally.
PMID:
30220979
PMCID:
PMC6135690
DOI:
10.18632/oncotarget.26066
Abstract
[This corrects the article DOI: 10.18632/oncotarget.3611.].
Publication types
Published Erratum